Literature DB >> 19837154

Detection of gyrA and gyrB mutations in Clostridium difficile isolates by real-time PCR.

Patrizia Spigaglia1, Alessandra Carattoli, Fabrizio Barbanti, Paola Mastrantonio.   

Abstract

Fluoroquinolone (FQ)-resistance in Clostridium difficile has been associated with mutations in the quinolone-resistance determining region (QRDR) of gyr genes. In particular, the majority of resistant clinical isolates show mutations in codon 82 of gyrA or in codon 426 of gyrB. A real-time PCR method was developed to identify these mutations in FQ-resistant C. difficile strains. Twenty-one clinical isolates, selected as representative of the different gyr alleles known up to date, and 20 clinical isolates with unknown behavior towards FQs were used to validate the method. Each mutation was detected by real-time amplification followed by hybridization with two fluorescent probes designed with the sequence complementary to the wild-type sequences of gyr genes. The melting peak analysis of the probe-PCR product hybrid was performed on a LightCycler (Roche Diagnostic). Single and multiplex assays were performed with the same reaction conditions. In both cases, isolates showing mutations in gyr sequences had a well distinguished T(m) compared to that of isolates showing wild-type genes or silent mutated codons in the nucleotide region covered by probes. The results obtained indicate that this real-time PCR assay is a rapid, reproducible and accurate screening method of the predominant mutations determining FQ-resistance in C. difficile strains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837154     DOI: 10.1016/j.mcp.2009.10.002

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  6 in total

1.  Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.

Authors:  Patrizia Spigaglia; Fabrizio Barbanti; Anna Maria Dionisi; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

2.  Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile.

Authors:  Vincenzo Forgetta; Matthew T Oughton; Pascale Marquis; Ivan Brukner; Ruth Blanchette; Kevin Haub; Vince Magrini; Elaine R Mardis; Dale N Gerding; Vivian G Loo; Mark A Miller; Michael R Mulvey; Maja Rupnik; Andre Dascal; Ken Dewar
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

Review 3.  Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.

Authors:  Miklos Fuzi; Dora Szabo; Rita Csercsik
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

4.  Emergence and global spread of epidemic healthcare-associated Clostridium difficile.

Authors:  Miao He; Fabio Miyajima; Paul Roberts; Louise Ellison; Derek J Pickard; Melissa J Martin; Thomas R Connor; Simon R Harris; Derek Fairley; Kathleen B Bamford; Stephanie D'Arc; Jon Brazier; Derek Brown; John E Coia; Gill Douce; Dale Gerding; Hee Jung Kim; Tse Hsien Koh; Haru Kato; Mitsutoshi Senoh; Tom Louie; Stephen Michell; Emma Butt; Sharon J Peacock; Nick M Brown; Tom Riley; Glen Songer; Mark Wilcox; Munir Pirmohamed; Ed Kuijper; Peter Hawkey; Brendan W Wren; Gordon Dougan; Julian Parkhill; Trevor D Lawley
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

5.  Emergence and spread of moxifloxacin-resistant Clostridium difficile ribotype 231 in Sweden between 2006 and 2015.

Authors:  H Harvala; E Alm; T Åkerlund; K Rizzardi
Journal:  New Microbes New Infect       Date:  2016-09-16

6.  Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents.

Authors:  Miklos Fuzi; Jesus Rodriguez Baño; Akos Toth
Journal:  Front Microbiol       Date:  2020-02-25       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.